We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Sets out COVID-19 testing for hospice patients and staff.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
An annual publication providing statistics on restricted patients in England and Wales
Latest news and press releases, information on meetings and events, public consultations and related patient safety information.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Practical advice for clinicians caring for immunocompromised persons who wish to travel or who have travelled to Zika-affected countries or areas.
Advice and guidance on the health needs of migrant patients from Colombia for healthcare practitioners.
How to use an ethnographic study to evaluate your digital health product.
Urgent public health message on coronavirus (COVID-19) hospitalised cases who have travelled from China in the preceding 14 days.
The independent advisory group identified which patient groups are at highest risk of serious illness from COVID-19 and would benefit from new COVID-19 treatments.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.